XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Operating activities    
Net income $ 31,155 $ 34,529
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation 10,429 7,988
Amortization of intangible assets 16,014 11,175
Amortization of original issue discount and deferred financing costs 2,122 3,344
Loss on extinguishment of debt [1] 4,795
Deferred income taxes 9,072 8,935
Share-based compensation expense [2] 5,386 5,090
Other 46 285
Net changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (9,389) 29,944
Inventories (1,046) (66,312)
Other assets 2,297 (3,198)
Accounts payable 17,537 17,377
Accrued wages and employee benefits 6,166 (1,735)
Other accrued liabilities (1,825) (1,744)
Excess tax benefits from equity awards (6,729) (8,894)
Net cash provided by operating activities 81,235 41,579
Investing activities    
Proceeds from sale of property and equipment 47 88
Expenditures for property and equipment (14,004) (14,258)
Acquisition of business, net of cash acquired (60,886) 233
Net cash used in investing activities (74,843) (13,937)
Financing activities    
Proceeds from short-term borrowings 10,278 9,000
Proceeds from long-term borrowings 100,000
Repayments of short-term borrowings (6,327) (11,366)
Repayments of long-term borrowings and capital lease obligations (10,652) (150,453)
Stock repurchases (34,576)
Payment of debt issuance costs (2,060)
Cash dividends paid (76) (1,427)
Taxes paid related to the net share settlement of equity awards (12,099) (12,347)
Excess tax benefits from equity awards 6,729 8,901
Net cash used in financing activities (46,723) (59,752)
Effect of exchange rate changes on cash and cash equivalents 115 (2,076)
Net decrease in cash and cash equivalents (40,216) (34,186)
Cash and cash equivalents at beginning of period 115,857 189,761
Cash and cash equivalents at end of period $ 75,641 $ 155,575
[1] Represents the write-off of original issue discount and capitalized debt issuance costs due to voluntary debt prepayments.
[2] Represents share-based compensation expense to account for stock options, restricted stock and other stock awards over their respective vesting periods.